Veterinary Medicines

AFILARIA SR 3.4 mg/ml powder and solvent for suspension for injection for dogs

Authorised
  • Moxidectin
Download as PDF

Product identification

Medicine name:
AFILARIA SR 3.4 mg/ml powder and solvent for suspension for injection for dogs
Afilaria SR, 3,4mg/ml, Prášek a rozpouštědlo pro injekční suspenzi
Active substance:
  • Moxidectin
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Moxidectin
    100.00
    milligram(s)/gram
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB02
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:
  • Cardboard box with 1 powder vial containing 197,3 mg, 1 solvent vial with 5,67 ml and 1 adapter for reconstitution and withdrawal, 1 syringe and 1 needle.
  • Cardboard box with 1 powder vial containing 197,3 mg, 1 solvent vial with 5,67 ml and 1 adapter for reconstitution and withdrawal.
  • Cardboard box with 1 powder vial containing 592 mg, 1 solvent vial with 17 ml and 1 adapter for reconstitution and withdrawal, 1 syringe and 1 needle.
  • Cardboard box with 1 powder vial containing 592 mg, 1 solvent vial with 17 ml and 1 adapter for reconstitution and withdrawal.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 96/020/22-C
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0315/001
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • Czechia
  • France
  • Greece
  • Hungary
  • Italy
  • Portugal
  • Romania
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/04/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

Package Leaflet

English (PDF)
Published on: 12/04/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

Labelling

English (PDF)
Published on: 12/04/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

eu-PUAR-afilaria-sr-3.4-mg-ml-powder-and-solvent-for-suspension-for-injection-for-dogs-en.pdf

English (PDF)
Published on: 12/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."